esophageal cancer Clinical Trials and Research
Also known as: esophageal carcinoma, cancer of the esophagus, gullet cancer, eac, escc · ICD-10: C15
Esophageal cancer develops in the tube that carries food from your throat to your stomach. Clinical trial research is actively exploring new therapies, better diagnostic methods, and ways to improve patient outcomes. Find a Trial helps patients search for active studies investigating this condition.
Search esophageal cancer trials →
Common questions about esophageal cancer clinical trials
Who can participate in esophageal cancer clinical trials?
Eligibility criteria vary by study, often including factors like cancer stage, overall health, and prior treatments. Researchers use these criteria to ensure patient safety and collect relevant data. Patients should review specific study requirements carefully.
What are the different phases of clinical trials for esophageal cancer?
Esophageal cancer trials progress through phases 1, 2, and 3, testing safety, effectiveness, and comparing new treatments to existing ones. Phase 4 studies monitor approved therapies post-market, as documented on ClinicalTrials.gov.
Do clinical trials for esophageal cancer cost money to participate?
Generally, study-related medical costs are covered by the trial sponsor, but routine care costs may be billed to insurance. Patients should always clarify financial responsibilities with the study team before joining a trial.
What new treatments are being studied for esophageal cancer?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores immunotherapies, targeted therapies, novel chemotherapy combinations, and advanced radiation techniques for esophageal cancer. Studies also focus on improving surgical approaches and supportive care.
What types of interventions are common in esophageal cancer clinical trials?
Interventions often include new drug regimens (chemotherapy, immunotherapy, targeted therapy), radiation therapy, surgical techniques, or combinations of these. Some trials also investigate supportive care and quality of life improvements for patients.
Are there specific biomarkers relevant to esophageal cancer clinical trials?
Yes, studies often investigate biomarkers like HER2 status, PD-L1 expression, and specific genetic mutations to identify patients who might respond best to targeted therapies or immunotherapies, according to data from ClinicalTrials.gov.
What are common reasons someone might be excluded from an esophageal cancer trial?
Common exclusion criteria can include advanced comorbidities, certain prior treatments, specific cancer types not under study, or inadequate organ function. These ensure patient safety and the integrity of the research data collected.
Are there clinical trials focused on early detection or prevention of esophageal cancer?
Yes, some trials, documented on ClinicalTrials.gov and NIH RePORTER, investigate screening methods for high-risk individuals, such as those with Barrett's esophagus, and strategies to prevent progression to cancer or detect it at earlier stages.
How to find a esophageal cancer trial that fits you
- Describe your esophageal cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all esophageal cancer trials →